Forsta AP Fonden Has $148.74 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Forsta AP Fonden lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 254,400 shares of the healthcare conglomerate’s stock after purchasing an additional 19,400 shares during the period. UnitedHealth Group accounts for about 1.1% of Forsta AP Fonden’s investment portfolio, making the stock its 13th biggest holding. Forsta AP Fonden’s holdings in UnitedHealth Group were worth $148,743,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vicus Capital lifted its position in UnitedHealth Group by 278.5% during the 1st quarter. Vicus Capital now owns 1,813 shares of the healthcare conglomerate’s stock worth $897,000 after acquiring an additional 1,334 shares during the last quarter. Brown Miller Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 3.8% during the 1st quarter. Brown Miller Wealth Management LLC now owns 5,916 shares of the healthcare conglomerate’s stock worth $2,926,000 after purchasing an additional 219 shares during the period. Atticus Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 71.8% during the 1st quarter. Atticus Wealth Management LLC now owns 603 shares of the healthcare conglomerate’s stock worth $299,000 after purchasing an additional 252 shares during the period. New Mexico Educational Retirement Board increased its holdings in shares of UnitedHealth Group by 13.0% during the 1st quarter. New Mexico Educational Retirement Board now owns 54,720 shares of the healthcare conglomerate’s stock worth $27,906,000 after purchasing an additional 6,300 shares during the period. Finally, Physician Wealth Advisors Inc. increased its holdings in shares of UnitedHealth Group by 74.6% during the 1st quarter. Physician Wealth Advisors Inc. now owns 695 shares of the healthcare conglomerate’s stock worth $326,000 after purchasing an additional 297 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $564.56 on Friday. The firm’s 50 day moving average is $583.52 and its 200-day moving average is $537.96. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The firm has a market capitalization of $521.33 billion, a price-to-earnings ratio of 36.78, a PEG ratio of 1.67 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the business posted $6.56 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. Truist Financial restated a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, Bank of America lowered their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.